What is the AI therapy chatbot ban movement and how does it affect CRE investors? The AI therapy chatbot ban is a sweeping wave of state legislation that prohibits artificial intelligence systems from delivering clinical mental health therapy, psychotherapy, or independent mental health diagnoses. With 98 chatbot specific bills pending across 34 states and three federal proposals as of April 2026, this regulatory movement is reshaping the economics of healthcare real estate by forcing behavioral health services back into physical clinical spaces. For a comprehensive overview of how AI is transforming commercial real estate, see our complete guide on AI commercial real estate.
Key Takeaways
- 34 states have introduced 98 AI therapy chatbot bills in 2026, with Illinois, Nevada, California, and New York already enacting restrictions and Maine's LD 2082 awaiting the governor's signature.
- Therapy chatbot bans force behavioral health services into physical clinical spaces, directly increasing demand for medical office and outpatient facility square footage.
- Medical outpatient building occupancy has hit 93% nationally, the strongest in a decade per JLL, and therapy chatbot bans add further demand pressure in states with enacted restrictions.
- CRE investors should monitor the patchwork of state regulations, as compliance requirements vary widely and federal preemption remains uncertain under Trump's December 2025 executive order.
- Properties zoned for medical and behavioral health use in states with enacted chatbot bans will see accelerated demand from providers expanding physical footprints.
Why States Are Banning AI Therapy Chatbots
The legislative momentum behind AI therapy chatbot bans traces directly to high profile tragedies. In 2025, OpenAI was sued after a 16 year old California boy spent hours discussing suicide with ChatGPT before taking his own life. A similar case involved a 14 year old Florida boy who interacted with an AI chatbot that claimed to be a therapist. These incidents catalyzed bipartisan legislative action across the country.
Maine's LD 2082, formally titled the "Act to Regulate the Use of Artificial Intelligence in Providing Certain Mental Health Services," passed both chambers with a rare unanimous committee vote and was sent to the governor on April 8, 2026. The bill prohibits clinical AI use in mental health therapy while permitting administrative functions like note taking and scheduling. Missouri's HB 2372 includes a therapy chatbot ban with $10,000 penalties per violation, approved by the full House on April 2. Florida, Ohio, and New Jersey have active bills in committee.
At the federal level, Rep. Kevin Mullin (CA-15) introduced the CHATBOT Act (H.R. 7985), which would prohibit AI chatbots from impersonating licensed professionals in medical, legal, and financial fields. This activity contrasts sharply with Utah, which moved in the opposite direction by granting AI prescription authority for psychiatric medication renewals in early 2026.
The State Regulatory Landscape
Understanding the scope of this legislative wave is critical for CRE investors evaluating healthcare real estate across different markets:
- States with enacted bans: Illinois (HB 1806, August 2025), Nevada (AB 406, June 2025), California (companion chatbot law, effective January 1, 2026), New York (chatbot disclosure and crisis referral requirements), and New Mexico (counselor AI ethics regulations, effective November 2025)
- States with pending legislation: Maine (LD 2082, awaiting governor signature), Missouri (HB 2372, in Senate committee), Florida (pre filed for 2026 session), Ohio (introduced November 2025), and New Jersey (A5603, cleared committee)
- Federal proposals: The CHATBOT Act (H.R. 7985) and two additional federal bills address AI impersonation of licensed professionals
The Future of Privacy Forum tracks all 98 bills and notes that definitions of "chatbot" vary widely across jurisdictions, creating a compliance patchwork that affects healthcare operators and the real estate they occupy. Meanwhile, the Colorado AI Act taking effect June 2026 adds another layer of AI regulation affecting CRE investors.
Direct Impact on Healthcare Real Estate Demand
Therapy chatbot bans have a straightforward economic impact on CRE: they increase demand for physical healthcare space. When AI cannot legally deliver therapy, patients must see providers in person, and those providers need clinical facilities.
Medical Office and Outpatient Facilities
Behavioral health providers in states with chatbot bans must expand their physical footprints to meet demand that AI alternatives might otherwise absorb. According to JLL's 2026 Medical Outpatient Building Perspective, medical outpatient building occupancy has reached 93% nationally, the strongest in a decade, with limited new construction (starts down 29.3% from 2019) further tightening supply. Outpatient visits are forecast to increase by 227.4 million over the next five years, driven by population change and demographic shifts.
Key demand drivers from therapy chatbot bans include:
- New clinic openings: Behavioral health providers in banned states need additional treatment rooms, waiting areas, and administrative space to handle patient volumes that AI chatbots might have managed
- Renovation of existing space: General medical office properties are being converted to behavioral health use, requiring modifications for soundproofing, privacy compliance, and therapy specific layouts
- Rural and suburban expansion: Mental health access gaps in rural areas cannot be filled by AI chatbots in banned states, pushing providers to open satellite offices in underserved markets
Workforce and Space Demand Dynamics
According to HRSA, 137 million Americans (40% of the U.S. population) live in designated mental health professional shortage areas. HRSA's National Center for Health Workforce Analysis projects significant behavioral health workforce shortages through 2038, including psychiatrists, psychologists, counselors, and marriage and family therapists. Therapy chatbot bans mean this workforce gap cannot be partially offset by AI systems, intensifying the need for physical treatment facilities where available providers can see patients. Each licensed therapist typically requires 100 to 150 square feet of dedicated clinical space plus shared common areas, translating directly into medical office demand.
As AI scribes reshape healthcare economics, therapy chatbot bans create a counter trend: while AI administrative tools reduce some operational costs, the prohibition on clinical AI forces more physical space utilization for patient facing services.
Federal Preemption Risk
CRE investors must account for regulatory uncertainty. President Trump's December 2025 executive order, titled "Ensuring a National Policy Framework for Artificial Intelligence," proposes federal preemption of state AI laws deemed inconsistent with national policy. If Congress passes comprehensive federal AI legislation that preempts state therapy chatbot bans, the demand tailwind for healthcare CRE in banned states could reverse.
However, healthcare regulation has historically been a state domain, and bipartisan support for therapy chatbot bans (Maine's LD 2082 received a unanimous committee vote) suggests these laws may withstand preemption challenges. CRE investors should model both scenarios: continued state level bans driving medical office demand, and potential federal preemption creating market uncertainty.
Investment Strategy for Healthcare CRE
For personalized guidance on positioning healthcare CRE portfolios for the AI therapy regulation landscape, connect with The AI Consulting Network.
- Target states with enacted bans: Illinois, Nevada, California, New York, and New Mexico already have laws in effect. Medical office properties in these markets serving behavioral health tenants benefit from a regulatory moat that protects in person demand.
- Monitor pipeline states: Maine (imminent), Missouri, Florida, Ohio, and New Jersey could enact bans within 12 months. Early acquisition of medical office properties in these markets positions investors ahead of the demand curve.
- Evaluate tenant mix: Properties with behavioral health, psychiatry, and counseling tenants in banned states have stronger occupancy fundamentals. These tenants are less likely to consolidate or reduce space when AI clinical alternatives are prohibited.
- Assess cap rate dynamics: Medical office cap rates in markets with behavioral health demand typically range from 5.5% to 7.0%. In states with therapy chatbot bans, strong occupancy fundamentals and limited supply could compress cap rates (NOI divided by purchase price) by 25 to 50 basis points over the next 18 to 24 months.
CRE investors looking for hands on AI implementation support and regulatory analysis can reach out to Avi Hacker, J.D. at The AI Consulting Network.
Frequently Asked Questions
Q: Which states have already banned AI therapy chatbots?
A: As of April 2026, Illinois, Nevada, California, New York, and New Mexico have enacted laws restricting or banning AI systems from providing clinical mental health therapy. Maine's LD 2082 awaits the governor's signature, and Missouri's HB 2372 has passed the full House. The Future of Privacy Forum tracks 98 chatbot specific bills across 34 states.
Q: How do therapy chatbot bans increase healthcare CRE demand?
A: When AI cannot legally deliver therapy, patients must see providers in person. Providers need physical clinical spaces, including treatment rooms, waiting areas, and administrative offices. Each therapist requires 100 to 150 square feet of dedicated space. In states with bans, this demand cannot be offset by virtual AI alternatives, creating a regulatory floor under medical office occupancy.
Q: Could federal legislation preempt state therapy chatbot bans?
A: Potentially. Trump's December 2025 executive order proposes federal preemption of inconsistent state AI laws. However, healthcare regulation has traditionally been a state function, and therapy chatbot bans have bipartisan support. The CHATBOT Act (H.R. 7985) at the federal level would actually reinforce state bans rather than preempt them. CRE investors should model both scenarios in their underwriting.
Q: What types of CRE properties benefit most from therapy chatbot bans?
A: Medical office buildings with behavioral health, psychiatry, and counseling tenants in states with enacted bans see the strongest impact. Outpatient behavioral health facilities, rural satellite clinics, and properties zoned for medical use in underserved markets also benefit. Multi tenant medical office properties with existing therapy practices can expand behavioral health allocations to capture rising demand.